A group of researchers led by Nanyang Technological University, Singapore (NTU Singapore) discovered that a cancer medicine that is currently on the market might be modified to target a subgroup of malignancies that are frequently linked with poor outcomes and lack focused therapy choices.
A small but significant metabolic difference between human and mouse lung tumour cells, has been discovered by Weill Cornell Medicine researchers, explaining a discrepancy in previous study results, and pointing toward new strategies for developing cancer treatments.
Rice University scientists have enlisted widely used cancer therapy systems to control gene expression in mammalian cells, a feat of synthetic biology that could change how diseases are treated.
The study revealed the essential structural understandings of the mysterious but significant tankyrase protein, which is a key player in the development of bowel cancer.
According to Special Commissioner of Police, Crime Branch, RS Yadav, 2 engineers, a doctor and an MBA have been arrested in this connection. Three more accused persons are absconding and a search is on to nab them at the earliest, he added.
A ground-breaking discovery by a multinational team led by Penn State researchers has given new hope against malaria, which kills over 500,000 people each year, disproportionately impacting children under the age of five, pregnant women, and HIV patients.
New Delhi [India], September 13 (ANI): Four major anti-cancer drugs have been added to the National List of Essential Medicines (NLEM). The drugs included in the list are Bendamustine Hydrochloride, HCI Trihydrate, Lenalidomide and Leuprolide Acetate.
Boston [US], July 22 (ANI): Using nanoparticles to deliver cancer drugs allows for high drug concentrations to be delivered to tumours while avoiding the harmful side effects associated with chemotherapy. However, only a few nanoparticle-based cancer drugs have received FDA approval.
Washington [US], June 19 (ANI): A potential new way to treat chronic pain is using anti-cancer drugs rather than opioid-based pain medication, reveals a new study by the University of Calgary.